MetaCap

CVRx (CVRX) vs Picard Medical (PMI)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Picard Medical (PMI) has outperformed CVRx (CVRX) over the past year, losing 94.0% versus a loss of 94.9%. Picard Medical is the larger company by market cap ($18.1 million vs $14.3 million), about 1.3 times the size. CVRx converts more of its revenue into profit, with a net margin of -94.1% versus -546.6%.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

CVRX-94.91%PMI-94.02%
+71%-17%-105%
Nov 21, 20251 yearNov 20, 2026
CVRX-93.62%PMI-97.04%
+123%+7%-109%
Aug 25, 20255 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

CVRX versus PMI key metrics
MetricCVRXPMI
Share price$0.501$6.79
Market cap$14.27M$18.07M
1-day change-5.99%+7.78%
YTD return-92.94%-92.24%
1-year return-94.91%-94.02%
5-year return-96.13%—
P/E ratio (TTM)—3.04
EPS (TTM)$-2.00$2.23
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)$56.65M$4.94M
Revenue growth (YoY)+10.45%+12.50%
Net income (latest FY)$-53.31M$-27.00M
Gross margin85.33%-4.13%
Operating margin-90.49%-268.36%
Net margin-94.10%-546.60%
52-week high$10.28$208.00
52-week low$0.497$2.65
Distance from 52-week high-95.13%-96.74%
Analyst consensusnone—
Avg. price target upside+814.17%—
Average volume744.45K1.45M
Shares outstanding28.49M2.66M
Employees22375
SectorHealth CareHealth Care
IndustryMedical/Dental InstrumentsMedical/Dental Instruments

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • CVRx is more profitable, keeping -94.1 cents of every revenue dollar as net income versus -546.6 cents for Picard Medical.

About CVRx

CVRX stock →

CVRx, Inc., a commercial-stage medical device company, engages in developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases in the United States, Germany, and internationally. The company offers Barostim, an implantable device that delivers electrical pulses to baroreceptors located in the wall of the carotid artery to counteract decreased baroreceptor signaling, and provides baroreflex activation therapy, which links the cardiovascular system to the autonomic nervous system.

Health Care · Medical/Dental Instruments · 223 employees

About Picard Medical

PMI stock →

Picard Medical, Inc., together with its subsidiaries, engages in the designing, manufacturing, production, supply, marketing, and sale of medical device products. The company offers SynCardia TAH, an artificial heart for patients that is designed to function as a failed human heart in patients suffering from advanced heart failure.

Health Care · Medical/Dental Instruments · 75 employees

CVRX vs PMI FAQ

Which is bigger, CVRx or Picard Medical?

Picard Medical (PMI) is larger, with a market capitalization of $18.07M compared with $14.27M for CVRx (CVRX).

Which stock has performed better over the past year, CVRX or PMI?

PMI returned -94.02% over the past 12 months, compared with -94.91% for CVRX (price return, excluding dividends). Past performance does not predict future results.

Are CVRx and Picard Medical in the same industry?

Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.

More comparisons